AQR Capital Management
ANTH

AQR Capital Management’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

AQR Capital Management’s Portfolio ANTH Stock Details ANTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-15,602
Closed -$53K – 2259
2017
Q1 		$53K Buy
+15,602
New +$73.8K ﹤0.01% 2164
2016
Q2 		– Sell
-4,136
Closed -$120K – 2312
2016
Q1 		$120K Sell
4,136
-31,727
-88% -$861K ﹤0.01% 2174
2015
Q4 		$1.33M Buy
35,863
+2,444
+7% +$108K ﹤0.01% 1447
2015
Q3 		$1.63M Buy
33,419
+25,462
+320% +$1.78M ﹤0.01% 1224
2015
Q2 		$549K Buy
+7,957
New +$368K ﹤0.01% 1734

Other funds holding ANTH

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
ECM
Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return

AQR Capital Management's ANTH Position: Q2 2017 in Review

AQR Capital Management sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q2 2017, closing a stake of 15,602 shares — an estimated $53K sold.

AQR Capital Management first reported a position in ANTH in Q2 2015 and held it in 5 quarters. The position peaked at $1.63M in Q3 2015. 40 funds tracked by Wall St. Rank hold ANTH as of Q2 2017.

  • AQR Capital Management reported no remaining Anthera Pharmaceuticals, Inc. position as of Q2 2017 after selling out during the quarter.
  • AQR Capital Management sold 15,602 Anthera Pharmaceuticals, Inc. shares in Q2 2017, an estimated $53K.
  • AQR Capital Management first reported a position in Anthera Pharmaceuticals, Inc. in Q2 2015 and held it in 5 quarters.
  • AQR Capital Management's Anthera Pharmaceuticals, Inc. position peaked at $1.63M in Q3 2015.
  • 40 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q2 2017.

Based on AQR Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.